Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)May 31, 2025 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (FY)May 31, 2023 | (FY)May 31, 2022 | |
|---|---|---|---|---|---|
| Total revenue | 14.36%36.27B | 13.16%31.71B | 11.46B | 12.78%28.03B | 24.85B |
| Cost of revenue | 16.06%29.96B | 7.87%25.82B | 9.28B | 17.47%23.93B | 20.37B |
| Gross profit | 6.93%6.31B | 44.08%5.9B | 2.18B | -8.56%4.09B | 4.48B |
| Operating expense | 29.12%5.82B | 7.00%4.51B | 1.17B | 27.98%4.21B | 3.29B |
| Operating profit | -64.98%487.27M | 1,273.95%1.39B | 1.01B | -110.00%-118.52M | 1.19B |
| Net non-operating interest income (expenses) | -71.35%-75.98M | -8.08%-44.34M | -11.6M | -47.56%-41.03M | -27.81M |
| Non-operating interest income | 330.65%2.52M | 196.45%584K | --179K | -65.74%197K | --575K |
| Non-operating interest expense | 74.72%78.5M | 8.98%44.93M | --11.78M | 45.26%41.23M | --28.38M |
| Net investment income | -52.01%-2.95M | 49.43%-1.94M | -858K | -126.25%-3.84M | 14.63M |
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||
| Income from associates and other participating interests | |||||
| Special income (charges) | 74.43%-5.99M | -133.21%-23.43M | -1.19M | 550.28%70.56M | 10.85M |
| Less:Other special charges | -121.29%-4.99M | 124.73%23.43M | --1.19M | -294.51%-94.75M | ---24.02M |
| Less:Write off | --10.98M | --0 | ---- | 83.71%24.19M | --13.17M |
| Other non-operating income (expenses) | -347.60%-10.28M | -54.95%4.15M | 1.46M | -13.85%9.21M | 10.7M |
| Income before tax | -70.43%392.07M | 1,685.67%1.33B | 999.11M | -107.00%-83.61M | 1.19B |
| Income tax | -55.87%192.23M | 15,975.00%435.61M | 290.48M | -100.65%-2.74M | 420.1M |
| Net income | -77.55%199.83M | 1,200.80%890.17M | 708.64M | -110.45%-80.87M | 774.02M |
| Net income continuous operations | -77.55%199.83M | 1,200.79%890.17M | --708.64M | -110.45%-80.87M | --774.02M |
| Noncontrolling interests | |||||
| Net income attributable to the company | -77.55%199.83M | 1,200.80%890.17M | 708.64M | -110.45%-80.87M | 774.02M |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -77.55%199.83M | 1,200.80%890.17M | 708.64M | -110.45%-80.87M | 774.02M |
| Gross dividend payment | |||||
| Basic earnings per share | -77.55%51.14 | 1,200.80%227.7763 | 181.3265 | -110.45%-20.6918 | 198.0581 |
| Diluted earnings per share | -77.70%50.8 | 1,200.80%227.7763 | 181.3265 | -110.45%-20.6918 | 198.0581 |
| Dividend per share | 45.33 | ||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |